Status: current, Defined. Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3763205013 | Product containing precisely salicylic acid 50 microgram/1 milligram and zinc oxide 200 microgram/1 milligram conventional release cutaneous powder (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3763206014 | Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 2 | |
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 1 | |
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Has concentration strength denominator unit | mg | true | Inferred relationship | Some | 2 | |
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Count of base of active ingredient | 2 | false | Inferred relationship | Some | ||
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Has concentration strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Has concentration strength numerator value | 50 | false | Inferred relationship | Some | 1 | |
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Has concentration strength numerator value | 200 | false | Inferred relationship | Some | 2 | |
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Has precise active ingredient | Zinc oxide | true | Inferred relationship | Some | 2 | |
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Has BoSS | Zinc oxide | true | Inferred relationship | Some | 2 | |
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Has precise active ingredient | Salicylic acid | true | Inferred relationship | Some | 1 | |
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Has concentration strength denominator unit | mg | true | Inferred relationship | Some | 1 | |
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Has concentration strength numerator unit | mcg | true | Inferred relationship | Some | 2 | |
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Has BoSS | Salicylic acid | true | Inferred relationship | Some | 1 | |
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Is a | Salicylic acid and zinc oxide only product in cutaneous dose form | true | Inferred relationship | Some | ||
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Plays role | Antifungal therapeutic role | true | Inferred relationship | Some | ||
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Is a | Salicylic acid- and zinc oxide-containing product | false | Inferred relationship | Some | ||
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Has manufactured dose form | Cutaneous powder | true | Inferred relationship | Some | ||
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Is a | Salicylic acid in topical dosage form | false | Inferred relationship | Some | ||
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Has active ingredient | Zinc oxide | false | Inferred relationship | Some | ||
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Has active ingredient | Salicylic acid | false | Inferred relationship | Some | ||
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Is a | Zinc in topical dosage form | false | Inferred relationship | Some | ||
| Salicylic acid 50 microgram/mg and zinc oxide 200 microgram/mg cutaneous powder | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set
FHIR